Back
Sep 29
Education
EDU 15 - ASTRO/ILROG Joint Session: The Comeback of RT - Radiation Therapy is Back in the Frontline of Managing Hodgkin and Indolent Lymphomas
MODERATOR(S)
Joachim Yahalom, MD, FASTRO - Memorial Sloan Kettering Cancer Center
session DESCRIPTION
In the past decade, the role of radiation therapy in lymphomas has shifted significantly. While initially there appeared to be data supporting a decreased need for RT in the frontline settings for non-Hodgkin and Hodgkin lymphomas, recent data showing unforeseen toxicities from chemotherapy, as well as changing approaches to using radiation therapy in lymphomas have solidified that radiation therapy is more important than ever in the frontline setting.
learning objectives
- Describe short- and long-term toxicities of chemotherapies used to treat common lymphomas, including secondary malignancies.
- Discuss new studies on how to best use radiation therapy in the front line setting for Hodgkin lymphoma and indolent NHL.
Credits
| AMA PRA Category 1 Credits: | 1.00 |
Presentations
-
08:00am - 09:00am PT
ASTRO/ILROG Joint Session: The Comeback of RT - Radiation Therapy is Back in the Frontline of Managing Hodgkin and Indolent Lymphomas
Speaker: Joanna Yang, MD, MPH - Washington University in St Louis, St Louis -
08:00am - 08:02am PT
Introductions
Speaker: Joachim Yahalom, MD, FASTRO - Memorial Sloan Kettering Cancer Center, New York -
08:02am - 08:17am PT
Updated and New Randomized Studies That Established the Necessity of RT in Early Stage HL
Speaker: George Mikhaeel, MD, MBBS - Guys and St. Thomas NHS Foundation Trust, London -
08:10am - 08:20am PT
Short and Long-term Toxicity Concerns from Common Chemotherapies used to Treat Lymphoma
Speaker: Joachim Yahalom, MD, FASTRO - Memorial Sloan Kettering Cancer Center, New York -
08:17am - 08:32am PT
When, How, and Why Should We Use Very Low Dose RT in Indolent Lymphomas?
Speaker: Brandon Imber, MD, MS - Memorial Sloan Kettering Cancer Center, New York -
08:32am - 08:47am PT
Short and Long-term Toxicity Concerns from Common Chemotherapies used to Treat Lymphoma
Speaker: Joanna Yang, MD, MPH - Washington University in St Louis, St Louis -
08:47am - 09:00am PT
Questions and Answers
Speaker: Joachim Yahalom, MD, FASTRO - Memorial Sloan Kettering Cancer Center, New York